Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist

Dr. Skupsky outlines practical approaches to evaluating atypical pigmented lesions, emphasizing how ancillary testing can support clinical decision-making and improve diagnostic accuracy. Her discussion focuses on integrating newer diagnostic tools alongside traditional examination techniques to better assess melanoma risk.

Topics Covered

  • Clinical evaluation of atypical pigmented lesions
  • The role of dermoscopy in lesion assessment
  • Ancillary testing options to aid diagnosis and risk stratification
  • When to monitor versus biopsy suspicious lesions

 

Explore Related Resources

MORE EXPERT PERSPECTIVES IN MELANOMA

Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist

Dr. Skupsky outlines practical approaches to evaluating atypical pigmented lesions, emphasizing how ancillary testing can support clinical decision-making and improve diagnostic accuracy. Her discussion focuses

Jason Rizzo, MD, PhD: Evaluating Melanoma-specific Survival Stratification and Survival Benefit of Gene Testing in Patients with Melanoma

Dr. Rizzo presents research from the 2025 AAD Annual Meeting demonstrating the real-world impact of the 31-gene expression profile (31-GEP) test in patients with cutaneous